News: Anvisa Regulatory Sandbox and Global Updates
May 11, 2026
Anvisa advances its Regulatory Sandbox initiative for personalized cosmetics while global regulators strengthen post-market surveillance.
Updates, guidance and expert perspectives on regulatory affairs, compliance and market access across Brazil, the United States and Europe.
Anvisa advances its Regulatory Sandbox initiative for personalized cosmetics while global regulators strengthen post-market surveillance.
In addition to the MDR/IVDR review, unique device identification codes in China were given a final deadline. Learn more.
Understand the concept of regulatory reliance and how initiatives from IMDRF, FDA, and Anvisa are impacting global regulation.
Learn how MDR CE Mark certification for medical devices works and prepare your product for successful entry into the European Union market.
Understand the impacts of the EU MDR IVDR on the European market and the key global regulatory movements shaping the future.
While the FDA strengthens cosmetic recalls, the EU and China are making important regulatory updates.
Discover the truth behind the “Anvisa bans fiberglass nails” topic and explore other important regulatory updates.
Malaysia joins MDSAP, expanding global audits. Plus: FDA software guidance, IMDRF PCCP guideline, and Anvisa’s new import process.
Key changes for your biocompatibility strategy.
A practical guide to understand the 2025 update and what it means for your medical device documentation.
Subscribe to our newsletter to receive the latest updates and insights.
You may unsubscribe at any time using the link in our newsletter.